Literature DB >> 9163576

Evidence for a dual function of oxytocin in the control of growth hormone secretion in rats.

E Björkstrand1, A L Hulting, K Uvnäs-Moberg.   

Abstract

The aim of the present study was to investigate the role of oxytocin (Oxy) in the control of growth hormone (GH) release. Oxy was administered subcutaneously (s.c.) or intracerebroventricularly (i.c.v.) to male rats. The animals were decapitated and trunk blood was collected at 30 and 120 min after Oxy administration. GH levels were analyzed by radioimmunoassay. Oxy (100 microg, s.c) increased plasma levels of GH significantly 30 min after administration. Oxy (2 ng, i.c.v.) caused a significant rise of GH after 120 min. This effect was completely abolished by previous administration of the Oxy antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin. When 5 microg of Oxy were given i.c.v. or 1 mg s.c., an inhibition of GH secretion was seen after 120 min. This effect was also abolished by the Oxy antagonist. Thus Oxy may influence GH in opposite directions depending on the doses given.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163576     DOI: 10.1016/s0167-0115(96)02101-5

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  3 in total

1.  Variations in the response of pituitary lactotrophs to oxytocin during the rat estrous cycle.

Authors:  Joël Tabak; Arturo E Gonzalez-Iglesias; Natalia Toporikova; Richard Bertram; Marc E Freeman
Journal:  Endocrinology       Date:  2010-02-22       Impact factor: 4.736

2.  Central actions of the nonpeptide growth hormone secretagogue GHS-25.

Authors:  A R Bailey; L Gilliver; G Leng; R G Smith
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

3.  Direct stimulatory effects of oxytocin in female rat gonadotrophs and somatotrophs in vitro: comparison with lactotrophs.

Authors:  Arturo E Gonzalez-Iglesias; Patrick A Fletcher; José A Arias-Cristancho; Ruth Cristancho-Gordo; Cleyde V Helena; Richard Bertram; Joël Tabak
Journal:  Endocrinology       Date:  2014-11-19       Impact factor: 4.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.